BioPharm News

Apr 20, 2018
By BioPharm International Editors
FDA’s Center for Drug Evaluation and Research has published its second annual report on key safety programs and activities.
Apr 20, 2018
By BioPharm International Editors
LNC Therapeutics has appointed a new CEO and is strengthening its R&D for gut microbiome-based drugs.
Apr 20, 2018
By BioPharm International Editors
The agency has released new guidance on the development of new medication-assisted treatments for opioid dependence.
Apr 20, 2018
By BioPharm International Editors
The new platform is expected to speed up cell line development.
Apr 19, 2018
By BioPharm International Editors
Johnson & Johnson’s Janssen partners with Bristol-Myers Squibb to advance next-generation therapies for cardiovascular diseases.
Apr 19, 2018
By BioPharm International Editors
The agency has granted breakthrough therapy designation to Roche’s hemophilia therapy for treating hemophilia A in patients without factor VIII inhibitors.
Apr 19, 2018
By BioPharm International Editors
The company unveiled three new products to support single-use biomanufacturing and won an award for best technological innovation at INTERPHEX 2018.
Apr 19, 2018
By BioPharm International Editors
The new document answers questions regarding implementation of the ICH Q7 guidance on GMPs for APIs.
Apr 19, 2018
By BioPharm International Editors
The transaction is part of Merck KGaA’s strategy to actively shape its product portfolio and focus on innovation-driven business.
Apr 19, 2018
By BioPharm International Editors
Global investment firm Advent to acquire and invest in Sanofi’s European generics business, Zentiva, to boost its position in European market.
native1_300x100
lorem ipsum